NewsReal-World Study Of 6,000+ Medicare Patients With Advanced Prostate Cancer Shows Adding PROVENGE® (Sipuleucel-T) To Treatment Regimen Reduced Risk Of Death By 45%
February 13, 2020
Real-World Study Of 6,000+ Medicare Patients With Advanced Prostate Cancer Shows Adding PROVENGE® (Sipuleucel-T) To Treatment Regimen Reduced Risk Of Death By 45%